Long-Chain Fatty Acid Oxidation Disorders In-Clinic Disease Monitoring Program
Summary
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Ultragenyx Pharmaceutical Inc
- Links
- Ultragenyx Patient Advocacy/LC-FAOD Disease Information
- ID
- NCT04632953
- Study Type
- Observational
- Participants
- Expecting 300 study participants
- Last Updated